DocuSign price target lowered to $75 from $85 at UBS

UBS analyst Karl Keirstead lowered the firm’s price target on DocuSign (DOCU) to $75 from $85 and keeps a Neutral rating on the shares post the Q3 report. The firm says the company’s outlook “falls a bit short.”